Structure-based gene targeting discovery of sphaerimicin, a bacterial translocase i inhibitor

  • Masanori Funabashi
  • , Satoshi Baba
  • , Toshio Takatsu
  • , Masaaki Kizuka
  • , Yasuo Ohata
  • , Masahiro Tanaka
  • , Koichi Nonaka
  • , Anatol P. Spork
  • , Christian Ducho
  • , Wei Chen Leyla Chen
  • , Steven G. Van Lanen

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Rise and shine: Using a gene-targeting approach aimed at identifying potential L-threonine:uridine-5′-transaldolases that catalyze the formation of (5′S,6′S)-C-glycyluridine, a new bacterial translocase I inhibitor was discovered from an actinomycete following fermentation optimization.

Original languageEnglish
Pages (from-to)11607-11611
Number of pages5
JournalAngewandte Chemie - International Edition
Volume52
Issue number44
DOIs
StatePublished - Oct 25 2013

Funding

FundersFunder number
National Institutes of Health (NIH)AI087849
National Institute of Allergy and Infectious F32-AI286447 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI168214 Jason W. Rosch Diseases National Institute of Allergy and Infectious P30 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R00-AI166116 Christopher D. Radka Diseases National Institute of Allergy and Infectious T32-AI106700 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI192221 Jason W. Rosch Diseases National Inst...R01AI087849

    Keywords

    • actinomycetes
    • bacterial translocase I inhibitor
    • gene targeting
    • nucleoside antibiotics
    • transaldolase

    ASJC Scopus subject areas

    • Catalysis
    • General Chemistry

    Fingerprint

    Dive into the research topics of 'Structure-based gene targeting discovery of sphaerimicin, a bacterial translocase i inhibitor'. Together they form a unique fingerprint.

    Cite this